| NCT04414618 |
A Study of Opaganib in Coronavirus Disease 2019 Pneumonia |
https://ClinicalTrials.gov/show/NCT04414618 |
Recruiting |
RedHill Biopharma Limited |
2020-09-30 |
| NCT04461353 |
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers |
https://ClinicalTrials.gov/show/NCT04461353 |
Recruiting |
Pulmoquine Therapeutics, Inc |
2020-08-01 |
| NCT04452565 |
NA-83, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04452565 |
Recruiting |
NeuroActiva, Inc. |
2020-12-15 |
| NCT04413968 |
COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants |
https://ClinicalTrials.gov/show/NCT04413968 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-09-02 |
| NCT04397692 |
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) |
https://ClinicalTrials.gov/show/NCT04397692 |
Recruiting |
Beyond Air Ltd |
2020-09-30 |
| NCT04381936 |
Randomised Evaluation of COVID-19 Therapy |
https://ClinicalTrials.gov/show/NCT04381936 |
Recruiting |
University of Oxford |
2021-12-31 |
| NCT04379037 |
Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04379037 |
Recruiting |
Nemechek Technologies |
2020-09-01 |
| NCT04376684 |
Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease |
https://ClinicalTrials.gov/show/NCT04376684 |
Recruiting |
GlaxoSmithKline |
2020-12-21 |
| NCT04373733 |
Early Intervention in COVID-19: Favipiravir Verses Standard Care |
https://ClinicalTrials.gov/show/NCT04373733 |
Recruiting |
Chelsea and Westminster NHS Foundation Trust |
2021-03-31 |
| NCT04353336 |
Efficacay of Chloroquine in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04353336 |
Recruiting |
Tanta University |
2020-07-23 |
| NCT04342650 |
Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04342650 |
Completed |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
2020-05-14 |
| NCT04336410 |
Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04336410 |
Recruiting |
Inovio Pharmaceuticals |
2021-07-31 |
| NCT04327206 |
BCG Vaccination to Protect Healthcare Workers Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04327206 |
Recruiting |
Murdoch Childrens Research Institute |
2020-10-30 |
| NCT04323527 |
Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 |
https://ClinicalTrials.gov/show/NCT04323527 |
Completed |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
2020-05-07 |
| NCT04305457 |
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04305457 |
Active, not recruiting |
Massachusetts General Hospital |
2021-04-01 |
| NCT03331445 |
Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections |
https://ClinicalTrials.gov/show/NCT03331445 |
Active, not recruiting |
University of British Columbia |
2020-12-31 |
| NCT03301090 |
A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051 |
https://ClinicalTrials.gov/show/NCT03301090 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2019-01-19 |
| NCT04356495 |
Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04356495 |
Recruiting |
University Hospital, Bordeaux |
2020-12-31 |
| NCT04327401 |
COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III |
https://ClinicalTrials.gov/show/NCT04327401 |
Active, not recruiting |
Hospital Sirio-Libanes |
2020-08-30 |
| NCT04324463 |
Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial |
https://ClinicalTrials.gov/show/NCT04324463 |
Recruiting |
Population Health Research Institute |
2020-12-31 |
| NCT04453852 |
Monovalent Recombinant COVID19 Vaccine |
https://ClinicalTrials.gov/show/NCT04453852 |
Recruiting |
Vaxine Pty Ltd |
2021-07-01 |
| NCT04449276 |
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04449276 |
Recruiting |
CureVac AG |
2021-08-31 |
| NCT04416919 |
Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment |
https://ClinicalTrials.gov/show/NCT04416919 |
Recruiting |
University of Oklahoma |
2025-05-31 |
| NCT04394377 |
Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial |
https://ClinicalTrials.gov/show/NCT04394377 |
Recruiting |
Brazilian Clinical Research Institute |
2020-12-31 |
| NCT04343729 |
Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 |
https://ClinicalTrials.gov/show/NCT04343729 |
Active, not recruiting |
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
2020-06-16 |
| NCT04327388 |
Sarilumab COVID-19 |
https://ClinicalTrials.gov/show/NCT04327388 |
Recruiting |
Sanofi |
2020-07-31 |
| NCT04312009 |
Losartan for Patients With COVID-19 Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04312009 |
Recruiting |
University of Minnesota |
2021-04-01 |
| NCT04252885 |
The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection |
https://ClinicalTrials.gov/show/NCT04252885 |
Completed |
Guangzhou 8th People’s Hospital |
2020-04-30 |
| NCT04407208 |
Convalescent Plasma Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04407208 |
Completed |
Biofarma |
2020-06-22 |
| NCT04335084 |
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04335084 |
Recruiting |
ProgenaBiome |
2021-06-30 |
| NCT04334512 |
A Study of Quintuple Therapy to Treat COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04334512 |
Recruiting |
ProgenaBiome |
2021-06-30 |
| NCT04445454 |
Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04445454 |
Recruiting |
University of Liege |
2022-09-30 |
| NCT04444700 |
A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04444700 |
Recruiting |
University of Sao Paulo General Hospital |
2020-10-31 |
| NCT04443673 |
Glycine Supplement for Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04443673 |
Recruiting |
Instituto Nacional de Enfermedades Respiratorias |
2021-02-28 |
| NCT04433949 |
Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04433949 |
Recruiting |
Emory University |
2022-05-30 |
| NCT04424134 |
BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization |
https://ClinicalTrials.gov/show/NCT04424134 |
Recruiting |
Lomonosov Moscow State University Medical Research and Educational Center |
2020-07-18 |
| NCT04421664 |
Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) |
https://ClinicalTrials.gov/show/NCT04421664 |
Recruiting |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2020-07-01 |
| NCT04414267 |
Bacillus Calmette-guérin Vaccination to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04414267 |
Recruiting |
Hellenic Institute for the Study of Sepsis |
2021-05-25 |
| NCT04412356 |
Timing of Tracheotomy in Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04412356 |
Recruiting |
Sahlgrenska University Hospital, Sweden |
2020-12-01 |
| NCT04411602 |
Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD |
https://ClinicalTrials.gov/show/NCT04411602 |
Recruiting |
Ascension South East Michigan |
2020-12-31 |
| NCT04406246 |
Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide |
https://ClinicalTrials.gov/show/NCT04406246 |
Recruiting |
Materno-Perinatal Hospital of the State of Mexico |
2020-12-31 |
| NCT04403100 |
Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” |
https://ClinicalTrials.gov/show/NCT04403100 |
Recruiting |
Cardresearch |
2020-09-03 |
| NCT04398004 |
Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early |
https://ClinicalTrials.gov/show/NCT04398004 |
Recruiting |
Hellenic Institute for the Study of Sepsis |
2022-05-06 |
| NCT04395144 |
COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss |
https://ClinicalTrials.gov/show/NCT04395144 |
Recruiting |
Hôpital de Verdun |
2020-10-30 |
| NCT04393792 |
SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 |
https://ClinicalTrials.gov/show/NCT04393792 |
Recruiting |
Hampshire Hospitals NHS Foundation Trust |
2020-08-31 |
| NCT04392778 |
Clinical Use of Stem Cells for the Treatment of Covid-19 |
https://ClinicalTrials.gov/show/NCT04392778 |
Recruiting |
SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi |
2020-07-31 |
| NCT04391179 |
Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 |
https://ClinicalTrials.gov/show/NCT04391179 |
Recruiting |
University of Michigan |
2020-12-31 |
| NCT04391140 |
Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS |
https://ClinicalTrials.gov/show/NCT04391140 |
Recruiting |
Hospital Universitari Vall d’Hebron Research Institute |
2020-12-31 |
| NCT04390477 |
Study to Evaluate the Effect of a Probiotic in COVID-19 |
https://ClinicalTrials.gov/show/NCT04390477 |
Recruiting |
Bioithas SL |
2020-07-31 |
| NCT04390412 |
Low Dose Radiotherapy in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04390412 |
Recruiting |
Shahid Beheshti University of Medical Sciences |
2020-08-31 |
| NCT04390022 |
Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial |
https://ClinicalTrials.gov/show/NCT04390022 |
Recruiting |
Clinica Universidad de Navarra, Universidad de Navarra |
2020-08-04 |
| NCT04389385 |
COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) |
https://ClinicalTrials.gov/show/NCT04389385 |
Active, not recruiting |
TC Erciyes University |
2020-09-30 |
| NCT04388826 |
COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 |
https://ClinicalTrials.gov/show/NCT04388826 |
Recruiting |
Veru Inc. |
2020-07-30 |
| NCT04385836 |
Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
https://ClinicalTrials.gov/show/NCT04385836 |
Recruiting |
Ministry of Health, Saudi Arabia |
2020-09-01 |
| NCT04385199 |
Convalescent Plasma for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04385199 |
Recruiting |
Henry Ford Health System |
2020-08-01 |
| NCT04384380 |
Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04384380 |
Recruiting |
Taoyuan General Hospital |
2020-06-30 |
| NCT04382768 |
Inhaled Ibuprofen to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04382768 |
Recruiting |
QuÃmica Luar SRL |
2021-01-31 |
| NCT04382391 |
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms |
https://ClinicalTrials.gov/show/NCT04382391 |
Recruiting |
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) |
2020-09-01 |
| NCT04382040 |
A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 |
https://ClinicalTrials.gov/show/NCT04382040 |
Recruiting |
MGC Pharmaceuticals d.o.o |
2020-07-31 |
| NCT04380519 |
Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04380519 |
Recruiting |
R-Pharm |
2020-10-15 |
| NCT04379531 |
LDCT in COVID-19 Pneumonia: a Prospective Moscow Study |
https://ClinicalTrials.gov/show/NCT04379531 |
Completed |
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department |
2020-05-22 |
| NCT04378738 |
Social Media and Covid19 Pandemic |
https://ClinicalTrials.gov/show/NCT04378738 |
Enrolling by invitation |
Acibadem University |
2020-05-07 |
| NCT04376476 |
Host-pathogen Interactions During SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04376476 |
Recruiting |
Hospices Civils de Lyon |
2021-06-05 |
| NCT04376034 |
Convalescent Plasma Collection and Treatment in Pediatrics and Adults |
https://ClinicalTrials.gov/show/NCT04376034 |
Recruiting |
West Virginia University |
2021-03-30 |
| NCT04375397 |
Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury |
https://ClinicalTrials.gov/show/NCT04375397 |
Recruiting |
AbbVie |
2020-08-13 |
| NCT04375098 |
Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04375098 |
Recruiting |
Pontificia Universidad Catolica de Chile |
2020-12-31 |
| NCT04374565 |
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia |
https://ClinicalTrials.gov/show/NCT04374565 |
Recruiting |
University of Virginia |
2021-04-05 |
| NCT04369456 |
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients |
https://ClinicalTrials.gov/show/NCT04369456 |
Recruiting |
Centre Hospitalier Universitaire de Nice |
2020-10-22 |
| NCT04368377 |
Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04368377 |
Completed |
University of Milan |
2020-04-23 |
| NCT04367662 |
Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 |
https://ClinicalTrials.gov/show/NCT04367662 |
Completed |
University Hospital, Rouen |
2020-05-14 |
| NCT04366791 |
Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04366791 |
Recruiting |
Emory University |
2020-10-23 |
| NCT04366089 |
Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora |
https://ClinicalTrials.gov/show/NCT04366089 |
Recruiting |
Azienda Policlinico Umberto I |
2020-10-30 |
| NCT04365101 |
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19) |
https://ClinicalTrials.gov/show/NCT04365101 |
Recruiting |
Celularity Incorporated |
2020-11-30 |
| NCT04364737 |
Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04364737 |
Recruiting |
NYU Langone Health |
2023-01-31 |
| NCT04363593 |
Serology COVID-19 From the Cornwall Hospital Union |
https://ClinicalTrials.gov/show/NCT04363593 |
Recruiting |
Centre Hospitalier de Cornouaille |
2020-11-04 |
| NCT04363450 |
Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) |
https://ClinicalTrials.gov/show/NCT04363450 |
Recruiting |
Louisiana State University Health Sciences Center in New Orleans |
2020-07-06 |
| NCT04363437 |
COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04363437 |
Recruiting |
Maimonides Medical Center |
2020-05-31 |
| NCT04361838 |
The COVID-19 ICU PRAYER Study |
https://ClinicalTrials.gov/show/NCT04361838 |
Recruiting |
Kansas City Heart Rhythm Institute |
2020-08-31 |
| NCT04361526 |
Pilot Study on Cytokine Filtration in COVID-19 ARDS |
https://ClinicalTrials.gov/show/NCT04361526 |
Recruiting |
Hospital Clinic of Barcelona |
2020-07-31 |
| NCT04359810 |
Plasma Therapy of COVID-19 in Critically Ill Patients |
https://ClinicalTrials.gov/show/NCT04359810 |
Recruiting |
Columbia University |
2020-12-31 |
| NCT04358783 |
Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia |
https://ClinicalTrials.gov/show/NCT04358783 |
Recruiting |
Hospital Universitario Dr. Jose E. Gonzalez |
2021-02-01 |
| NCT04357782 |
Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation |
https://ClinicalTrials.gov/show/NCT04357782 |
Recruiting |
Hunter Holmes Mcguire Veteran Affairs Medical Center |
2020-06-01 |
| NCT04357730 |
Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04357730 |
Recruiting |
Denver Health and Hospital Authority |
2020-09-30 |
| NCT04357327 |
Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04357327 |
Recruiting |
Università degli Studi dell’Insubria |
2020-05-31 |
| NCT04357106 |
COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma |
https://ClinicalTrials.gov/show/NCT04357106 |
Recruiting |
Centro de HematologÃa y Medicina Interna |
2020-07-31 |
| NCT04355728 |
Use of UC-MSCs for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04355728 |
Recruiting |
University of Miami |
2021-04-30 |
| NCT04355637 |
Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia |
https://ClinicalTrials.gov/show/NCT04355637 |
Recruiting |
Fundacion Clinic per a la Recerca Biomédica |
2020-08-31 |
| NCT04353271 |
Trial of Hydroxychloroquine In Covid-19 Kinetics |
https://ClinicalTrials.gov/show/NCT04353271 |
Active, not recruiting |
University of South Alabama |
2020-07-01 |
| NCT04353128 |
Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. |
https://ClinicalTrials.gov/show/NCT04353128 |
Recruiting |
Instituto de Investigación Hospital Universitario La Paz |
2020-10-31 |
| NCT04353037 |
PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine |
https://ClinicalTrials.gov/show/NCT04353037 |
Recruiting |
UnitedHealth Group |
2021-04-30 |
| NCT04348370 |
BCG Vaccine for Health Care Workers as Defense Against COVID 19 |
https://ClinicalTrials.gov/show/NCT04348370 |
Recruiting |
Texas A&M University |
2021-05-31 |
| NCT04347382 |
Honey & Nigella Sativa Trial Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04347382 |
Recruiting |
Sheikh Zayed Federal Postgraduate Medical Institute |
2020-08-25 |
| NCT04346589 |
Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04346589 |
Recruiting |
A.O. Ospedale Papa Giovanni XXIII |
2020-08-31 |
| NCT04345289 |
Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04345289 |
Recruiting |
Hvidovre University Hospital |
2021-06-15 |
| NCT04344106 |
Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study |
https://ClinicalTrials.gov/show/NCT04344106 |
Recruiting |
Centre Hospitalier Intercommunal Aix-Pertuis |
2020-04-15 |
| NCT04343053 |
Pro-thrombotic Status in Patients With SARS-Cov-2 Infection |
https://ClinicalTrials.gov/show/NCT04343053 |
Active, not recruiting |
University Hospital of Ferrara |
2020-06-09 |
| NCT04342169 |
University of Utah COVID-19 Hydrochloroquine Trial |
https://ClinicalTrials.gov/show/NCT04342169 |
Recruiting |
University of Utah |
2022-04-30 |
| NCT04341493 |
Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04341493 |
Recruiting |
Materno-Perinatal Hospital of the State of Mexico |
2020-08-30 |
| NCT04341441 |
Will Hydroxychloroquine Impede or Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04341441 |
Recruiting |
Henry Ford Health System |
2020-06-30 |
| NCT04341415 |
Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome |
https://ClinicalTrials.gov/show/NCT04341415 |
Recruiting |
Fondation Ophtalmologique Adolphe de Rothschild |
2020-07-31 |
| NCT04340557 |
Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04340557 |
Recruiting |
Sharp HealthCare |
2020-10-06 |
| NCT04339712 |
Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction |
https://ClinicalTrials.gov/show/NCT04339712 |
Recruiting |
Hellenic Institute for the Study of Sepsis |
2022-04-01 |
| NCT04338841 |
HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04338841 |
Recruiting |
University Hospital, Angers |
2020-06-01 |
| NCT04337918 |
Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04337918 |
Recruiting |
Sanotize Research and Development corp. |
2020-08-31 |
| NCT04335786 |
Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease |
https://ClinicalTrials.gov/show/NCT04335786 |
Recruiting |
Radboud University |
2020-12-31 |
| NCT04334928 |
Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel |
https://ClinicalTrials.gov/show/NCT04334928 |
Recruiting |
Plan Nacional sobre el Sida (PNS) |
2020-06-30 |
| NCT04334629 |
LIBERATE Trial in COVID-19 |
https://ClinicalTrials.gov/show/NCT04334629 |
Recruiting |
King’s College London |
2020-09-25 |
| NCT04334044 |
Treatment of SARS Caused by COVID-19 With Ruxolitinib |
https://ClinicalTrials.gov/show/NCT04334044 |
Recruiting |
Grupo Cooperativo de HemopatÃas Malignas |
2020-06-01 |
| NCT04333368 |
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS |
https://ClinicalTrials.gov/show/NCT04333368 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-08-31 |
| NCT04332991 |
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease |
https://ClinicalTrials.gov/show/NCT04332991 |
Active, not recruiting |
Massachusetts General Hospital |
2020-07-31 |
| NCT04331808 |
CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) |
https://ClinicalTrials.gov/show/NCT04331808 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-03-31 |
| NCT04328467 |
Pre-exposure Prophylaxis for SARS-Coronavirus-2 |
https://ClinicalTrials.gov/show/NCT04328467 |
Active, not recruiting |
University of Minnesota |
2020-08-31 |
| NCT04328129 |
Household Transmission Investigation Study for COVID-19 in French Guiana |
https://ClinicalTrials.gov/show/NCT04328129 |
Recruiting |
Institut Pasteur |
2022-03-23 |
| NCT04327505 |
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04327505 |
Recruiting |
Karolinska Institutet |
2021-12-31 |
| NCT04327349 |
Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial |
https://ClinicalTrials.gov/show/NCT04327349 |
Enrolling by invitation |
Mazandaran University of Medical Sciences |
2020-05-20 |
| NCT04326452 |
Treating COVID-19 With a Bidirectional Oxygenation Valve |
https://ClinicalTrials.gov/show/NCT04326452 |
Recruiting |
TMC HealthCare |
2020-05-01 |
| NCT04326426 |
ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04326426 |
Enrolling by invitation |
Vanda Pharmaceuticals |
2020-08-01 |
| NCT04326036 |
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04326036 |
Enrolling by invitation |
Healeon Medical Inc |
2021-11-01 |
| NCT04324528 |
Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation |
https://ClinicalTrials.gov/show/NCT04324528 |
Recruiting |
University Hospital Freiburg |
2020-09-26 |
| NCT04322682 |
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) |
https://ClinicalTrials.gov/show/NCT04322682 |
Recruiting |
Montreal Heart Institute |
2020-09-30 |
| NCT04322396 |
Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04322396 |
Recruiting |
Chronic Obstructive Pulmonary Disease Trial Network, Denmark |
2020-10-31 |
| NCT04322344 |
Escin in Patients With Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04322344 |
Recruiting |
University of Catanzaro |
2020-06-30 |
| NCT04322123 |
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) |
https://ClinicalTrials.gov/show/NCT04322123 |
Active, not recruiting |
Hospital do Coracao |
2020-08-30 |
| NCT04321616 |
The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients |
https://ClinicalTrials.gov/show/NCT04321616 |
Recruiting |
Oslo University Hospital |
2020-08-31 |
| NCT04321174 |
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir |
https://ClinicalTrials.gov/show/NCT04321174 |
Recruiting |
St. Michael’s Hospital, Toronto |
2021-03-31 |
| NCT04321096 |
The Impact of Camostat Mesilate on COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04321096 |
Recruiting |
University of Aarhus |
2020-12-31 |
| NCT04320238 |
Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff |
https://ClinicalTrials.gov/show/NCT04320238 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2020-05-31 |
| NCT04318015 |
Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) |
https://ClinicalTrials.gov/show/NCT04318015 |
Recruiting |
National Institute of Respiratory Diseases, Mexico |
2020-12-31 |
| NCT04316377 |
Norwegian Coronavirus Disease 2019 Study |
https://ClinicalTrials.gov/show/NCT04316377 |
Active, not recruiting |
University Hospital, Akershus |
2020-05-25 |
| NCT04315948 |
Trial of Treatments for COVID-19 in Hospitalized Adults |
https://ClinicalTrials.gov/show/NCT04315948 |
Recruiting |
Institut National de la Santé Et de la Recherche Médicale, France |
2023-03-31 |
| NCT04315896 |
Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) |
https://ClinicalTrials.gov/show/NCT04315896 |
Recruiting |
National Institute of Respiratory Diseases, Mexico |
2020-10-31 |
| NCT04312243 |
NO Prevention of COVID-19 for Healthcare Providers |
https://ClinicalTrials.gov/show/NCT04312243 |
Recruiting |
Massachusetts General Hospital |
2021-04-07 |
| NCT04308668 |
Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 |
https://ClinicalTrials.gov/show/NCT04308668 |
Completed |
University of Minnesota |
2020-05-20 |
| NCT04306393 |
Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 |
https://ClinicalTrials.gov/show/NCT04306393 |
Recruiting |
Massachusetts General Hospital |
2021-03-21 |
| NCT04282902 |
A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection |
https://ClinicalTrials.gov/show/NCT04282902 |
Recruiting |
Tongji Hospital |
2020-04-30 |
| NCT04276688 |
Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment |
https://ClinicalTrials.gov/show/NCT04276688 |
Completed |
The University of Hong Kong |
2020-03-30 |
| NCT04275414 |
Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04275414 |
Recruiting |
Qilu Hospital of Shandong University |
2020-04-30 |
| NCT03465085 |
Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS |
https://ClinicalTrials.gov/show/NCT03465085 |
Completed |
Beni-Suef University |
2018-01-30 |
| NCT04420247 |
Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 |
https://ClinicalTrials.gov/show/NCT04420247 |
Recruiting |
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva |
2020-08-31 |
| NCT04377672 |
Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04377672 |
Recruiting |
Johns Hopkins University |
2021-05-28 |
| NCT04325906 |
Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS |
https://ClinicalTrials.gov/show/NCT04325906 |
Recruiting |
Rush University Medical Center |
2020-08-31 |
| NCT04311177 |
Losartan for Patients With COVID-19 Not Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04311177 |
Recruiting |
University of Minnesota |
2021-04-01 |
| NCT04402879 |
CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals |
https://ClinicalTrials.gov/show/NCT04402879 |
Recruiting |
University of Calgary |
2020-12-01 |
| NCT04399889 |
hCT-MSCs for COVID19 ARDS |
https://ClinicalTrials.gov/show/NCT04399889 |
Recruiting |
Duke University |
2021-04-01 |
| NCT04357366 |
suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) |
https://ClinicalTrials.gov/show/NCT04357366 |
Recruiting |
Hellenic Institute for the Study of Sepsis |
2022-04-15 |
| NCT04402060 |
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04402060 |
Recruiting |
Apellis Pharmaceuticals, Inc. |
2020-11-30 |
| NCT04348695 |
Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. |
https://ClinicalTrials.gov/show/NCT04348695 |
Recruiting |
Fundación de investigación HM |
2020-05-13 |
| NCT04346667 |
Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds |
https://ClinicalTrials.gov/show/NCT04346667 |
Recruiting |
Government of Punjab, Specialized Healthcare and Medical Education Department |
2020-05-30 |
| NCT04328961 |
Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) |
https://ClinicalTrials.gov/show/NCT04328961 |
Recruiting |
University of Washington |
2020-09-30 |
| NCT04365985 |
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04365985 |
Recruiting |
William Beaumont Hospitals |
2021-05-31 |
| NCT04364893 |
Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 |
https://ClinicalTrials.gov/show/NCT04364893 |
Recruiting |
D’Or Institute for Research and Education |
2020-10-01 |
| NCT04361396 |
Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04361396 |
Recruiting |
Centre Hospitalier René Dubos |
2020-10-31 |
| NCT04321278 |
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) |
https://ClinicalTrials.gov/show/NCT04321278 |
Completed |
Hospital Israelita Albert Einstein |
2020-06-14 |
| NCT04311697 |
Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04311697 |
Recruiting |
NeuroRx, Inc. |
2020-08-31 |
| NCT04437823 |
Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04437823 |
Recruiting |
Jinnah Hospital |
2021-05-31 |
| NCT04349098 |
Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04349098 |
Recruiting |
Karyopharm Therapeutics Inc |
2020-08-31 |
| NCT04342728 |
Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation |
https://ClinicalTrials.gov/show/NCT04342728 |
Enrolling by invitation |
The Cleveland Clinic |
2020-12-30 |
| NCT04324073 |
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI |
https://ClinicalTrials.gov/show/NCT04324073 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-03-27 |
| NCT04322565 |
Colchicine Counteracting Inflammation in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04322565 |
Recruiting |
Azienda Ospedaliero-Universitaria di Parma |
2020-06-20 |
| NCT04318444 |
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04318444 |
Recruiting |
Columbia University |
2021-03-31 |
| NCT00215826 |
Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers |
https://ClinicalTrials.gov/show/NCT00215826 |
Completed |
AIM ImmunoTech Inc. |
2006-04-30 |
| NCT00150475 |
Contamination During Removal of Two Different Personal Protective Systems |
https://ClinicalTrials.gov/show/NCT00150475 |
Completed |
Queen’s University |
NA |